Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026)

Ocular Therapeutix has reported Raw Materials for 13 years, with the latest figure at $256000.0 in Q2 2026.

• Raw Materials for Q2 2026 came in at $256000.0, up 16.89% year-over-year; the trailing twelve-month figure through Jun 2026 was $256000.0 (up 16.89% YoY), and the FY2025 annual result was $202000.0, down 5.61% from the prior year.
• Raw Materials slipped to $256000.0 in Q2 2026, from $287000.0 in the prior quarter.
• Over five years, Raw Materials peaked at $341000.0 in Q2 2023 and troughed at $187000.0 in Q1 2025.
• A 5-year average of $268500.0 and a median of $277000.0 in 2024 frame the typical range for Raw Materials.
• The widest annual swing landed in 2025, when Raw Materials tumbled 43.16%; it then jumped 53.48% in 2026.
• A 5-year view of Raw Materials shows it stood at $309000.0 in 2022, then declined by 2.27% to $302000.0 in 2023, then fell by 29.14% to $214000.0 in 2024, then retreated by 5.61% to $202000.0 in 2025, then climbed by 26.73% to $256000.0 in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $256000.0 in Q2 2026, $287000.0 in Q1 2026, and $202000.0 in Q4 2025.